Cytosorbents Corp
CTSO
Market Cap$58.85M
Close$
$2.35
170.5% upside
Current Fair Value
170.5% upsideUndervalued by 170.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $58.85 Million |
|---|---|
| Enterprise Value | $82.89 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.38 |
| Beta | 1.17 |
| Outstanding Shares | 54,714,642 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.48 |
|---|---|
| PEG | -0.01 |
| Price to Sales | 0.01 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.01 |
| Enterprise Value to EBIT | -0.02 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 2.46 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Cytosorbents Corp
CEO: Phillip Chan